AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
Revenue
AFT Pharmaceuticals Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Revenue
NZ$174.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
BLIS Technologies Ltd
NZX:BLT
|
Revenue
NZ$10.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Cannasouth Ltd
NZX:CBD
|
Revenue
NZ$955.6k
|
CAGR 3-Years
94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Rua Bioscience Ltd
NZX:RUA
|
Revenue
NZ$357.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Revenue
NZ$550.9k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Revenue?
Revenue
174.5m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Revenue amounts to 174.5m NZD.
What is AFT Pharmaceuticals Ltd's Revenue growth rate?
Revenue CAGR 5Y
16%
Over the last year, the Revenue growth was 24%. The average annual Revenue growth rates for AFT Pharmaceuticals Ltd have been 18% over the past three years , 16% over the past five years .